PCN Insights, News, Videos, and More
News
06/25/2024
An investigational, once-monthly, subcutaneous long-acting injection of olanzapine called TEV-‘749 met its primary endpoint in the efficacy portion of the phase 3 SOLARIS trial.
An investigational, once-monthly, subcutaneous long-acting injection of olanzapine called TEV-‘749 met its primary endpoint in the efficacy portion of the phase 3 SOLARIS trial.
An investigational,...
06/25/2024
Psych Congress Network
News
06/25/2024
Exploratory outcomes from a phase 2a trial suggest that the first-in-class small molecule LM11A-31 slowed progression of pathophysiological features of mild to moderate Alzheimer disease (AD) over 26 weeks.
Exploratory outcomes from a phase 2a trial suggest that the first-in-class small molecule LM11A-31 slowed progression of pathophysiological features of mild to moderate Alzheimer disease (AD) over 26 weeks.
Exploratory outcomes from a...
06/25/2024
Psych Congress Network
News
06/25/2024
Attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of Lewy Body disease (LBD), according to results from a recent prospective observational cohort study published in The American Journal of Geriatric...
Attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of Lewy Body disease (LBD), according to results from a recent prospective observational cohort study published in The American Journal of Geriatric...
Attention-deficit/hyperactivity...
06/25/2024
Psych Congress Network
Videos
06/21/2024
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP,...
06/21/2024
Psych Congress Network
Q&As
06/20/2024
Nishi Bhopal, MD, telehealth practitioner, providers insight into how mental health clinicians can utilize social media to improve patient outcomes and combat misinformation.
Nishi Bhopal, MD, telehealth practitioner, providers insight into how mental health clinicians can utilize social media to improve patient outcomes and combat misinformation.
Nishi Bhopal, MD, telehealth...
06/20/2024
Psych Congress Network
News
06/19/2024
Lecanemab, a recently FDA-approved treatment for Alzheimer disease (AD) may have a low eligibility rate (6.2%) among patients aged 70-89 years, according to recent results published in the journal Neurology.
Lecanemab, a recently FDA-approved treatment for Alzheimer disease (AD) may have a low eligibility rate (6.2%) among patients aged 70-89 years, according to recent results published in the journal Neurology.
Lecanemab, a recently...
06/19/2024
Neurology
News
06/18/2024
Xanomeline-trospium chloride was efficacious and well-tolerated in adults with schizophrenia experiencing acute psychosis, according to trial results published in JAMA Psychiatry.
“In the phase 3 EMERGENT-3 trial in people with...
Xanomeline-trospium chloride was efficacious and well-tolerated in adults with schizophrenia experiencing acute psychosis, according to trial results published in JAMA Psychiatry.
“In the phase 3 EMERGENT-3 trial in people with...
Xanomeline-trospium chloride was...
06/18/2024
Psych Congress Network
Videos
06/18/2024
In this video, Dr Jain discusses possible cardiometabolic symptoms that can occur in bipolar disorder treatment and how clinicians can avoid them from the start.
In this video, Dr Jain discusses possible cardiometabolic symptoms that can occur in bipolar disorder treatment and how clinicians can avoid them from the start.
In this video, Dr Jain discusses...
06/18/2024
Psych Congress Network
News
06/13/2024
Adolescents with higher levels of adiposity may be more susceptible to the cognitive effects of sleep restriction than those with lower adiposity, according to a recent single-blind randomized crossover trial.
Adolescents with higher levels of adiposity may be more susceptible to the cognitive effects of sleep restriction than those with lower adiposity, according to a recent single-blind randomized crossover trial.
Adolescents with higher levels...
06/13/2024
Neurology
News
06/13/2024
Compared to those in the pre-menopause phase, perimenopausal patients are at a higher risk for depressive symptoms and diagnoses. Results from the systematic review and meta-analysis were published in The Journal of Affective...
Compared to those in the pre-menopause phase, perimenopausal patients are at a higher risk for depressive symptoms and diagnoses. Results from the systematic review and meta-analysis were published in The Journal of Affective...
Compared to those in the...
06/13/2024
Psych Congress Network
